000902740 001__ 902740
000902740 005__ 20250129092411.0
000902740 0247_ $$2doi$$a10.1007/s00259-020-05029-w
000902740 0247_ $$2ISSN$$a0340-6997
000902740 0247_ $$2ISSN$$a1432-105X
000902740 0247_ $$2ISSN$$a1619-7070
000902740 0247_ $$2ISSN$$a1619-7089
000902740 0247_ $$2Handle$$a2128/30705
000902740 0247_ $$2pmid$$a32935187
000902740 0247_ $$2WOS$$aWOS:000569571400002
000902740 037__ $$aFZJ-2021-04522
000902740 082__ $$a610
000902740 1001_ $$00000-0003-0378-8334$$aTiepolt, Solveig$$b0$$eCorresponding author
000902740 245__ $$a(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls
000902740 260__ $$aHeidelberg [u.a.]$$bSpringer-Verl.$$c2021
000902740 3367_ $$2DRIVER$$aarticle
000902740 3367_ $$2DataCite$$aOutput Types/Journal article
000902740 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1645005473_18216
000902740 3367_ $$2BibTeX$$aARTICLE
000902740 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000902740 3367_ $$00$$2EndNote$$aJournal Article
000902740 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000902740 536__ $$0G:(DE-Juel1)HGF-HVF-0012$$aNikotinPET - Validierung von (+)-[18F]Flubatine als PET-Radiotracer zur Untersuchung von Nikotinrezeptoren bei Demenz (HGF-HVF-0012)$$cHGF-HVF-0012$$x1
000902740 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000902740 7001_ $$0P:(DE-HGF)0$$aBecker, Georg-Alexander$$b1
000902740 7001_ $$0P:(DE-HGF)0$$aWilke, Stephan$$b2
000902740 7001_ $$0P:(DE-HGF)0$$aCecchin, Diego$$b3
000902740 7001_ $$0P:(DE-HGF)0$$aRullmann, Michael$$b4
000902740 7001_ $$0P:(DE-HGF)0$$aMeyer, Philipp M.$$b5
000902740 7001_ $$0P:(DE-HGF)0$$aBarthel, Henryk$$b6
000902740 7001_ $$0P:(DE-HGF)0$$aHesse, Swen$$b7
000902740 7001_ $$0P:(DE-HGF)0$$aPatt, Marianne$$b8
000902740 7001_ $$0P:(DE-HGF)0$$aLuthardt, Julia$$b9
000902740 7001_ $$0P:(DE-Juel1)133954$$aWagenknecht, Gudrun$$b10
000902740 7001_ $$aSattler, Bernhard$$b11
000902740 7001_ $$aDeuther-Conrad, Winnie$$b12
000902740 7001_ $$aLudwig, Friedrich-Alexander$$b13
000902740 7001_ $$aFischer, Steffen$$b14
000902740 7001_ $$aGertz, Hermann-Josef$$b15
000902740 7001_ $$aSmits, René$$b16
000902740 7001_ $$aHoepping, Alexander$$b17
000902740 7001_ $$aSteinbach, Jörg$$b18
000902740 7001_ $$aBrust, Peter$$b19
000902740 7001_ $$aSabri, Osama$$b20
000902740 773__ $$0PERI:(DE-600)2098375-X$$a10.1007/s00259-020-05029-w$$gVol. 48, no. 3, p. 731 - 746$$n3$$p731 - 746$$tEuropean journal of nuclear medicine and molecular imaging$$v48$$x0340-6997$$y2021
000902740 8564_ $$uhttps://juser.fz-juelich.de/record/902740/files/Tiepolt2021_Article_-%5B18F%5DFlubatineAsANovel%CE%914%CE%B22Nic.pdf$$yOpenAccess
000902740 909CO $$ooai:juser.fz-juelich.de:902740$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000902740 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133954$$aForschungszentrum Jülich$$b10$$kFZJ
000902740 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000902740 9141_ $$y2022
000902740 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-02
000902740 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000902740 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J NUCL MED MOL I : 2019$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-02-02$$wger
000902740 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000902740 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J NUCL MED MOL I : 2019$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-02-02
000902740 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-02-02
000902740 9201_ $$0I:(DE-Juel1)ZEA-2-20090406$$kZEA-2$$lZentralinstitut für Elektronik$$x0
000902740 9801_ $$aFullTexts
000902740 980__ $$ajournal
000902740 980__ $$aVDB
000902740 980__ $$aUNRESTRICTED
000902740 980__ $$aI:(DE-Juel1)ZEA-2-20090406
000902740 981__ $$aI:(DE-Juel1)PGI-4-20110106